Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, July 30, 2014
Technology Networks
Register | Sign in
Home Page>News

  News Archive

Novasep Appoints CEO Michel Spagnol as Chairman
Wednesday, March 05, 2014
Novasep presents strategic developments.

ProBioGen and Merus Sign Deal on GlymaxX® ADCC Enhancement Technology
Wednesday, March 05, 2014
GlymaxX® manufacturing technology improves bispecific antibody activity for solid tumor treatment.

Beckman Coulter, Wyatt Technology Partner
Tuesday, March 04, 2014
The companies will develop and market products designed for nanoparticle characterization.

Cobra Biologics, BioCancell Agreement for Promising Cancer Therapy Drug
Monday, March 03, 2014
The Companies have announced the agreement to manufacture BioCancell’s BC-821 cancer drug for clinical trials.

Rosetta Genomics to Receive U.S. Patent for Oncology Therapeutic
Thursday, February 27, 2014
Company receives a Notice of Allowance from the USPTO for a patent claiming Mp53-negative cancer patients.

NBE Announces Validation of its SMAC-Technology for ADC Development
Saturday, February 22, 2014
Successful validation of SMAC™-Technology at World ADC summit 2014 in Frankfurt, Germany.

Pluristem Submits FDA Orphan Drug Application for Preeclampsia
Saturday, February 22, 2014
Orphan Drug Designation may provide benefits including 7 year market exclusivity, tax credits, and FDA’s guidance on clinical studies.

Cytovance Biologics and Pamlico Biopharma Announce Agreement
Friday, February 21, 2014
Development and cGMP manufacturing agreement to advance the treatment of Streptococcus pneumoniae infections.

Proteros Elects New Supervisory Board Member
Thursday, February 20, 2014
Shareholders confirmed the appointment of Prof. Eric-Paul Pâques as a new member of the Supervisory Board.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 1057
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to